联合知名大学科研院所及企业开发药食两用植物标准品和天然植物有效单体,主打中药对照品/标准品/天然植物有效单体,小分子化合物库,药物杂质。所有产品仅用作科学研究,我们不为任何个人用途提供产品和服务。
Fields of Application :
Brivanib is an ATP-competitive inhibitor against human VEGFR2 and FGFR with IC50 of 25 nM and 148 nM, respectively.
| CAS Number: | 649735-46-6 |
| Purity: | >98% |
| Molecular Weight: | 370.38 |
| Molecular Formula: | C19H19FN4O3 |
Quality Control: HPLC、NMR、 LC/MS(Please contact us to get the QC report)
| Synonyms: | bms540215, bms 540215 |
| Chemical Name: | (R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[1,2-f][1,2,4]triazin-6-yloxy)propan-2-ol |
| Storage: | 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
Note: Products for research use only, not for human use
Description:
Brivanib is the hydrolyzed Form of Brivanib alaninate, which is a vascular endothelial growth factor receptor 2 (VEGFR2) inhibitor with potential antineoplastic activity. Brivanib strongly binds to and inhibits VEGFR2, a tyrosine kinase receptor expressed almost exclusively on vascular endothelial cells; inhibition of VEGFR2 may result in inhibition of tumor angiogenesis, inhibition of tumor cell growth, and tumor regression. Check For active clinical trials or closed clinical trials using this agent. (NCI Thesaurus). For the detailed information about the solubility of Brivanib (bms-540215) in water, the solubility of Brivanib (bms-540215) in DMSO, the solubility of Brivanib (bms-540215) in PBS buffer, the animal experiment(test) of Brivanib (bms-540215),the in vivo,in vitro and clinical trial test of Brivanib (bms-540215),the cell experiment(test) of Brivanib (bms-540215),the IC50, EC50 and Affinity of Brivanib (bms-540215).
References:
C(OC1=CN2C(=C1C)C(OC1C=CC3=C(C=1F)C=C(C)N3)=NC=N2)C(O)C
暂时还没有评价
|
|
|
|
|
结构式搜索